CPHI 2026 – 23/07/2026
PCI Drug-Device 28/05/2026

Current Edition

ramusmedical
news

Antibiotic resistance: Pherecydes Pharma raises €8.7M ($10.3M)

Pherecydes Pharma, a biotechnology company specialized in the research and development of anti-infective therapies based on the use of bacteriophages, today announces...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026